Document is current

Any future updates will be listed below

731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis

Crossref DOI link: https://doi.org/10.1136/jitc-2020-SITC2020.0731

Published Online: 2020-12-10

Published Print: 2020-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark